IMNN · Imunon
AI read · Bad for IMNN
The AI's read
Ovation 3 enrollment and site openings are tracking to plan. The National Cancer Institute agreement also creates room to study the treatment for other illnesses without taking resources from the main trial. Imunon sold rights to ThermoDox to focus on that program. Still, the company says it needs more money to reach its enrollment goals. That funding need makes completing the main study depend on raising more money, so it outweighs the progress reported.